Related Experiment Video
Updated: Jul 7, 2025

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
3.6K
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open
Kazuhiko Yoshida1, Nao Oida1, Tsunenori Kondo2
1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Summary
Robot-assisted laparoscopic partial nephrectomy (reRAPN) offers a reduced surgical burden compared to repeat open partial nephrectomy (reOPN) for recurrent renal cell carcinoma, with similar renal function outcomes.
Area of Science:
- Urology
- Surgical Oncology
- Nephrology
Background:
- Recurrent renal cell carcinoma (RCC) necessitates repeat nephron-sparing surgery (NSS).
- Comparing repeat open partial nephrectomy (reOPN) and robot-assisted laparoscopic partial nephrectomy (reRAPN) is crucial for optimizing patient outcomes.
Purpose of the Study:
- To evaluate and compare the surgical and functional outcomes of reOPN versus reRAPN.
- To determine the efficacy and safety of minimally invasive reRAPN for recurrent RCC.
Main Methods:
- Retrospective analysis of 39 patients (22 reOPN, 17 reRAPN) who underwent repeat NSS.
- Data collected included operative time, estimated blood loss, complication rates (Clavien-Dindo grade ≥2), and postoperative renal function (eGFR).
- Trifecta achievement (negative margins, no major complications, and normal renal function) was assessed.
Main Results:
- No significant differences in patient demographics, tumor characteristics, or nephrometry score.
- ReRAPN demonstrated significantly shorter operative times and less estimated blood loss compared to reOPN.
- Higher complication rates (Clavien-Dindo grade ≥2) were observed in the reOPN group.
- Trifecta achievement rates were significantly higher in the reRAPN group (64.7%) than in the reOPN group (27.3%).
- Postoperative renal function (eGFR decrease at 3 months) showed no significant difference between the groups.
Conclusions:
- ReRAPN is associated with a reduced surgical burden compared to reOPN.
- Both reOPN and reRAPN yield comparable postoperative renal functional outcomes.
- ReRAPN represents a valuable minimally invasive surgical option for managing recurrent renal cell carcinoma.

